{"url_path":"/sec/tvrd/8-k/2026-05-08/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1346830/0001104659-26-057524-index.html","accession_number":"0001104659-26-057524","cik":"0001346830","ticker":"TVRD","issuer_name":"Tvardi Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1346830/0001104659-26-057524-index.html","primary_entity_key":"0001346830","primary_entity_name":"Tvardi Therapeutics, Inc."},"word_count":82,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits.**\n\n** **\n\n**(d) Exhibits**\n\n** **\n\n**Exhibit No.**\n \n**Description**\n\n[99.1](tm2613977d1_ex99-1.htm)\n \n[Press release issued on May 8, 2026.](tm2613977d1_ex99-1.htm)\n\n \n \n \n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned\nhereunto duly authorized.\n\n \n\n \nTVARDI THERAPEUTICS, INC.\n\n \n \n\nDate: May 8, 2026\nBy:\n/s/ Imran Alibhai\n\n \nName:\nImran Alibhai\n\n \nTitle:\nChief Executive Officer"}